Potential role of β-elemene on histone H1 in the H22 ascites hepatoma cell line

Molecular Medicine Reports

Volumn 6, Issue 1, 2012, Pages 185-190

  Bao, Fazhen ^a   Qiu, Jie ^a   Zhang, Hong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Histone; Mechanism

Indexed keywords

BETA ELEMENE; FLUOROURACIL; HISTONE H1; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES HEPATOMA; ASCITES TUMOR CELL; CHINESE MEDICINE; CHROMATIN STRUCTURE; CONTROLLED STUDY; CURCUMA; DRUG DOSE COMPARISON; DRUG ISOLATION; DRUG MECHANISM; EPIGENETICS; GENE EXPRESSION; HERB; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION; HISTONES; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; SESQUITERPENES;

CURCUMA WENYUJIN; MURINAE;

EID: 84861649082     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.891     Document Type: Article

References (32)

1. Cha C, DeMatteo RP and Blumgart LH: Surgery and ablative therapy for hepatocellular carcinoma. J Clin Gastroenterol 35: S130-S137, 2002. (Pubitemid 35278650)
2. Thorgeirsson SS and Grisham JW: Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 340-346, 2002.
3. Horn PJ and Peterson CL: Chromatin higher order folding-wrapping up transcription. Science 297: 1824-1827, 2002. (Pubitemid 35024334)
4. Alami R, Fan Y, Pack S, Sonbuchner TM, Besse A, Lin O, Greally JM, Sokoultchi AI and Bouhassira EE: Mammalian linker-histone subtypes differentially affect gene expression in vivo. PNAS 100: 5920-5925, 2003. (Pubitemid 36576908)
5. Misteli T, Gunjan A, Hock R, Bustin M and Brown DT: Dynamic binding of histone H1 to chromatin in living cells. Nature 408: 877-881, 2000. (Pubitemid 32016100)
6. Ausio J: Histone H1 and evolution of sperm nuclear basic proteins. J Biol Chem 274: 31115-31118, 1999.
7. Happel N and Doenecke D: Histone H1 and its isoforms: contribution to chromatin structure and function. Gene 431: 1-12, 2009.
8. Izzo A, Kamieniarz K and Schneider R: The histone H1 family: specific members, specific functions? Biol Chem 389: 333-343, 2008. (Pubitemid 351773907)
9. Garcia BA, Busby SA, Barber CM, Shabanowitz J, Allis CD and Hunt DF: Characterization of phosphorylation sites on histone H1 isoforms by tandem mass spectrometry. J Proteome Res 3: 1219-1227, 2004. (Pubitemid 40040376)
10. Wisniewski JR, Zougman A, Kruger S and Mann M: Mass spectrometric mapping of linker histone H1 variants reveals multiple acetylations, methylations, and phosphorylation as well as differences between cell culture and tissue. Mol Cell Proteomics 6: 72-87, 2007. (Pubitemid 46152693)
11. Weiss T, Hergeth S, Zeissler U, Izzo A, Tropberger P, Zee BM, Dundr M, Garcia BA, Daujat S and Schneider R: Research histone H1 variant-specific lysine methylation by G9a/KMT1C and Glp1/KMT1D. Epigenet Chromatin 3: 7, 2010.
12. Vani G and Shyamala DC: Tumour suppressor activity of histone H1 in experimental mammary carcinoma. Indian J Pharmacol 32: 210-213, 2000. (Pubitemid 30433191)
13. Vani G, Devipriya S and Shyamaladevi CS: Histone H1 modulates immune status in experimental breast cancer. Chemotherapy 49: 252-256, 2003. (Pubitemid 37188096)
14. Fujisawa T, Joshi B and Puri R: Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer. J Transl Med 9: 37, 2011.
15. Clapier CR and Cairns BR: The biology of chromatin remodeling complexes. Annu Rev Biochem 78: 273-304, 2009.
16. Xu L, Tao S, Wang X, Yu Z, Wang M, Chen D, Jing Y and Dong J: The synthesis and anti-proliferative effects of β-elemene derivatives with mTOR inhibition activity. Bioorg Med Chem 14: 5351-5356, 2006. (Pubitemid 43922417)
17. Xu X, Zhou Z, Luo Y, Lu R, Men R and Fang D: Elemene-induced apoptosis of SMMC-7721 cells of human hepatocellular carcinoma. Acta Acad Med Mil Tert 4: 268-271, 1999.
18. Xie CY, Yang W, Li M, Ying J, Tao SJ, Li K, Dong JH and Wang XS: Cell apoptosis induced by delta-elemene in colorectal adenocarcinoma cells via a mitochondrial-mediated pathway. Yakugaku Zasshi 129: 1403-1413, 2009.
19. Li QQ, Wang G, Reed E, Huang L and Cuff CF: Evaluation of cisplatin in combination with beta-Elemene as a regimen for prostate cancer chemotherapy. Basic Clin Pharmacol Toxicol 107: 868-876, 2010.
20. Hill DA: Influence of linker histone H1 on chromatin remodeling. Biochem Cell Biol 79: 317-324, 2001.
21. Thomas JO: Histone H1: location and role. Curr Opin Cell Biol 11: 312-317, 1999.
22. Zlatanova J, Caiafa P and Van Holde K: Linker histone binding and displacement: versatile mechanism for transcriptional regulation. FASEB J 14: 1697-1704, 2000.
23. Shen X and Gorovsky MA: Linker histone H1 regulates specific gene expression but not global transcription in vivo. Cell 86: 475-483, 1996. (Pubitemid 26272087)
24. Marshall L and White RJ: Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer 8: 911-914, 2008.
25. Johnson SA, Dubeau L and Johnson DL: Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation. J Biol Chem 283: 19184-19191, 2008.
26. Hill DA and Reeves R: Competition between HMG-I(Y), HMG-1and histone H1 on four way junction DNA. Nucleic Acids Res 25: 3523-3531, 1997. (Pubitemid 27359231)
27. Zlatanova J and van Holde K: Linker histones versus HMG1/2: a struggle for dominance? Bio Essays 20: 584-588, 1998.
28. Catez F, Yang H, Tracey KJ, Reeves R, Misteli T and Bustin M: Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol Cell Biol 24: 4321-4328, 2004. (Pubitemid 41071002)
29. Tang D, Kang R, Zeh HJ III and Lotze MT: High-mobility group box 1 and cancer. Biochim Biophys Acta 1799: 131, 2010.
30. Gnanasekar M, Thirugnanam S and Ramaswamy K: Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis. Int J Oncol 34: 425-431, 2009.
31. Class R, Lindman S, Fassbender C, Leinenbach HP, Rawer S, Emrich JG, Brady LW and Zeppezauer M: Histone H1 suppresses tumor growth of leukemia cells in vitro, ex vivo and in an animal model suggesting extracellular functions of histones. Am J Clin Oncol 19: 522-531, 1996. (Pubitemid 26314887)
32. Widlak P, Kalinowska M, Parseghian MH, LuX, Hansen JC and Garrard WT: The histone H1 C-terminal domain binds to the apoptotic nuclease, DNA fragmentation factor (DFF40/CAD) and stimulates DNA cleavage. Biochemistry 44: 7871-7878, 2005. (Pubitemid 40740770)